Condition: Blood Clot · Thrombectomy · Ischemic Stroke · Sponsor: Henry Ford Health System
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
This description comes directly from the study's public registry record.
Alex Chebl, MD · 313-916-2644 · achebl1@hfhs.org
Kelly Tundo, RN · 313-916-1102 · kciach1@hfhs.org
Always discuss trial participation with your own doctor first.
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07363525